Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated with a Continuous Left Ventricular Assist Device

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

AIMS: Impaired left ventricular diastolic function leading to elevated left atrial pressures, particularly during exertion, is a key driver of symptoms and outcomes in heart failure with preserved ejection fraction (HFpEF). Insertion of an interatrial shunt device (IASD) to reduce left atrial pressure in HFpEF has been shown to be associated with short-term haemodynamic and symptomatic benefit. We aimed to investigate the potential effects of IASD placement on HFpEF survival and heart failure hospitalization (HFH).

METHODS AND RESULTS: Heart failure with preserved ejection fraction patients participating in the Reduce Elevated Left Atrial Pressure in Patients with Heart Failure study (Corvia Medical) of an IASD were followed for a median duration of 739 days. The theoretical impact of IASD implantation on HFpEF mortality was investigated by comparing the observed survival of the study cohort with the survival predicted from baseline data using the Meta-analysis Global Group in Chronic Heart Failure heart failure risk survival score. Baseline and post-IASD implant parameters associated with HFH were also investigated. Based upon the individual baseline demographic and cardiovascular profile of the study cohort, the Meta-analysis Global Group in Chronic Heart Failure score-predicted mortality was 10.2/100 pt years. The observed mortality rate of the IASD-treated cohort was 3.4/100 pt years, representing a 33% lower rate (P = 0.02). By Kaplan-Meier analysis, the observed survival in IASD patients was greater than predicted (P = 0.014). Baseline parameters were not predictive of future HFH events; however, poorer exercise tolerance and a higher workload-corrected exercise pulmonary capillary wedge pressure at the 6 months post-IASD study were associated with HFH.

CONCLUSIONS: The current study suggests IASD implantation may be associated with a reduction in mortality in HFpEF. Large-scale ongoing randomized studies are required to confirm the potential benefit of this therapy.

Original languageEnglish
JournalESC Heart Failure
Volume6
Issue number1
Pages (from-to)62-69
ISSN2055-5822
DOIs
Publication statusPublished - 2019

    Research areas

  • HFpEF, Heart failure, Interatrial shunt, Medical device, Survival, Heart Atria/physiopathology, Prospective Studies, Ventricular Function, Left/physiology, Atrial Pressure/physiology, Follow-Up Studies, Humans, Australia/epidemiology, Prostheses and Implants, Male, Stroke Volume/physiology, Cardiac Catheterization/methods, Heart Failure/mortality, New Zealand/epidemiology, Survival Rate/trends, Europe/epidemiology, Time Factors, Female, Aged, Hospitalization/trends

ID: 56234901